fig2

A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions

Figure 2. Characterization of dimethylbromobenzene-cysteine stapled peptide. A: Schematic diagram for the preparation of dimethylbromobenzene-cysteine stapled peptide; B: the table for the molecular weight and helicity of the p53-MDM2/MDMX inhibitor (PMI) and stapled peptides. CALC MW stands for the theoretical molecular weight of peptides. *Stand for that the molecular weight was measured by ESI-MASS; C: circular dichroism spectra of PMI, SP0, SP1, SP2 and SP3. The experiment was repeated independently for 3 times with similar results

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/